- Mike Lehmann Named President, Labs North America -
PRINCETON, N.J., Dec. 18 /PRNewswire-FirstCall/ -- Covance Inc. (NYSE: CVD) today announced that Wendel Barr has been named Covance's Chief Operating Officer, effective January 1, 2008. Mr. Barr, who is currently President of Early Development North America, will assume operating responsibility for Covance's business units worldwide and will report to Joe Herring, Covance's Chairman and Chief Executive Officer. In addition, Mike Lehmann, currently General Manager of the preclinical laboratory facility in Madison, Wis., was named President of Labs North America and will serve on Covance's Global Leadership Council.
"These moves reflect the depth and strength of our leadership talent that enables us to promote executives from within Covance," said Mr. Herring. "Wendel is a proven leader who has demonstrated exemplary management capabilities, a track record of accomplishment, and strong client focus, as reflected by the impressive growth and expansion of our Early Development North America operations. Wendel's appointment will allow me to further focus on strategies that would continue to drive growth and deliver value to our clients, employees, and shareholders."
Mr. Barr joined Covance in 2000 as Vice President and General Manager
of Labs North America. In 2003, he was promoted to President, Early
Development North America responsible for the company's North American
preclinical and global Phase I operations. Under his leadership, the Early
Development North America operations has grown significantly with
expansions in Madison, Wis., and planned construction in Chandler, Ariz.,
and Manassas, Va., as well as acquisitions in the Phase I service offering.
Prior to joining Covance, Mr. Barr was Global Vice President and General
Manager of Marconi Medical Systems. He also spent 15 years at GE in a broad
variety of positions of increasing responsibility. He holds an MBA from the
|SOURCE Covance Inc.|
Copyright©2007 PR Newswire.
All rights reserved